JPRN-UMIN000009407招募中未知
A combination phase I study of split doses of cisplatin plus etoposide with early concurrent accelerated hyperfractionated thoracic radiotherapy for elderly limited disease small cell lung cancer - A combination phase I study of split doses of cisplatin plus etoposide with early concurrent accelerated hyperfractionated thoracic radiotherapy for elderly limited disease small cell lung cancer
Department of Medical Oncology, Kinki University faculty of Medicine0 个研究点目标入组 18 人开始时间: 2012年11月27日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 18
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 70years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Severe infection and complication (hemorrhage and heart disease etc.) 2)Intestinal pneumonia or lung fibrosis 3)History of severe drug allergic reaction 4)Pregnant women or women willing child bearing 5)Men willing to have children 6)Uncontrolled diabetes 7)Uncontrolled pleural, cardiac, or abdominal effusion 8)Fever over 38 degrees Celsius 9)History of thoratic radiation 10)Inadequate condition diagnosed by primary physician
研究者
相似试验
招募中
2 期
A phase II trial of sequential treatment from cisplatin-etoposide therapy (PE) to irinotecan hydrochloride + amrubicin hydrochloride therapy with concomitant use of G-CSF nartograstim in patients with extensive-stage small cell lung cancer or advanced large cell neuroendocrine carcinoma (LCNEC)Extensive-stage small cell lung cancer and stage IIIB/IV large cell neuroendocrine carcinoma (LCNEC)JPRN-UMIN000006497Department of Respiratory Medicine Kitasato University School of Medicine31
尚未招募
3 期
Comparison of different doses of cisatracurium for intubatioCTRI/2024/03/064130iroo
已完成
2 期
Multicenter phase II study of S-1 plus Weekly Cisplatin in first-line treatment of unresectable or reccurent gastric cancergastric cancerJPRN-UMIN000001858Tsukuba Cancer Clinical Trial Group70
尚未招募
4 期
A Clinical trial to compare the effect of giving two priming doses of Inj.CisAtracurium in addition to its loading dose in general anaesthesiaCTRI/2023/07/055859Amreen Mehnaz A
已完成
1 期
A phase 1 clinical pharmacological study with a single oral dose of KAG-308JPRN-UMIN000011878Kaken Pharmaceutical Co., LTD60